General Chemical Hemostatic Preparations
Session
Dental Science
Description
Hemostasis is a physiological process that stops bleeding in the injured area while maintaining normal blood flow in the circulation. Hemostasis occurs in two phases, primary and secondary hemostasis. When this process is disrupted, bleeding occurs, which we monitor with hemostatic agents. Hemostatic agents are divided into active (biological) and passive agents (mechanical, chemical and physical). According to their mode of action, they are divided into local and systemic agents. The advantages of chemical hemostyptics over active agents are: the unlikelihood of disease transmission, longer duration of use, and lower cost. General hemostatic agents are used more as a prophylactic measure. Aim: This paper aims to introduce general hemostatic-chemical preparations for the management of bleeding, their dosage, side effects, when indicated and when contraindicated. Methodology: The paper is in the form of a "literature review". University books, world literature, both written and published in scientific journals in the form of text, illustrations or tables are used to collect data for this paper. Discussions: Numerous studies conducted by clinics around the world demonstrate that the administration of systemic chemical hemostyptics to patients with vascular disease is safe and has minimal side effects.
Keywords:
Hemostasis, bleeding, systemic chemical hemostatics
Proceedings Editor
Edmond Hajrizi
ISBN
978-9951-982-15-3
Location
UBT Kampus, Lipjan
Start Date
25-10-2024 9:00 AM
End Date
27-10-2024 6:00 PM
DOI
10.33107/ubt-ic.2024.185
Recommended Citation
Blakaj, Manjola; Blakaj, Learta; Ahmeti, Emel; and Bislimi, Tringa, "General Chemical Hemostatic Preparations" (2024). UBT International Conference. 17.
https://knowledgecenter.ubt-uni.net/conference/2024UBTIC/DS/17
General Chemical Hemostatic Preparations
UBT Kampus, Lipjan
Hemostasis is a physiological process that stops bleeding in the injured area while maintaining normal blood flow in the circulation. Hemostasis occurs in two phases, primary and secondary hemostasis. When this process is disrupted, bleeding occurs, which we monitor with hemostatic agents. Hemostatic agents are divided into active (biological) and passive agents (mechanical, chemical and physical). According to their mode of action, they are divided into local and systemic agents. The advantages of chemical hemostyptics over active agents are: the unlikelihood of disease transmission, longer duration of use, and lower cost. General hemostatic agents are used more as a prophylactic measure. Aim: This paper aims to introduce general hemostatic-chemical preparations for the management of bleeding, their dosage, side effects, when indicated and when contraindicated. Methodology: The paper is in the form of a "literature review". University books, world literature, both written and published in scientific journals in the form of text, illustrations or tables are used to collect data for this paper. Discussions: Numerous studies conducted by clinics around the world demonstrate that the administration of systemic chemical hemostyptics to patients with vascular disease is safe and has minimal side effects.